BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears undervalued ...

Sentiment plummeted to a seven-month low as one-year inflation expectations surged to their highest point since late 2023. The US economy added 143,000 jobs in January, fewer than expected. The ...

Scientists have unlocked a revolutionary way to generate proton beams using high-powered lasers and a simple stream of water.

Scientists have developed a method for generating fast, bright proton beams using a high-repetition-rate laser-plasma ...

Scientists just pulled off something straight out of a sci-fi movie—teleportation. But it’s not about moving people or ...

Blair County leaders are showing interest in a consulting company’s proposal to examine prison staffing levels and potential improvements through the use of computer software apps. While the initial ...

Researchers have been working for decades to understand the architecture of the subatomic world. One of the knottier ...

The construction industry faces potential financial strain and material price increases due to new tariffs on steel and ...

Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk ...